This is not only a competitive market for today’s entrepreneurs to raise funds, it is also a very competitive market for investors who want to cooperate with the most promising startups or even lead rounds of financing.Have a Record investment Among U.S. startups in 2021, the second quarter is the most Active in global IPOs Within 20 years. With such a large amount of available funds, the game has undergone a fundamental change.
Investors may now find themselves pitching to startups that are in high demand, not the other way around. Under these circumstances, it is important not only to choose the right company to invest in, but also to stand out from the competition in any possible way to develop long-term relationships.Because it’s no longer about who can write the biggest checks-it’s about who can bring the most checks value To the table.
Earlier this year, we worked hard and successfully won the opportunity to lead the C round of financing, which is for popular digital companies Healthcare Startups Thirty MadisonThis is completely changing the way patients with chronic diseases (including hair loss, migraines and allergies) receive continuous care. Together with other well-known investors, we finally led a $140 million financing to fund this growing company.
How do we determine that this particular healthcare company is worth the extra effort, and how do we make a deal in such a crowded field? Here are four key takeaways for other investors hoping to strike a successful deal with the most promising healthcare startups:
- Identify value that other people don’t have
There is a growing trend patience Become consumer, Take medical care in your own hands, and require more convenience than traditional treatment modes. Thirty Madison directly meets this need through multiple independent brands, each of which provides innovative, convenient and effective treatments for different chronic diseases-this is no secret. However, what really caught our interest was another matter and prompted us to maintain close contact with them through two rounds of financing, and finally led their C round of financing.
What makes the difference? We know that Thirty Madison is developing its business to focus on solving patients facing higher vision conditions and building corporate solutions to provide solutions for pharmaceutical companies and employers. Although other investors may only focus on the existing direct-to-consumer business, we see great potential for this kind of business expansion.
By looking at the value of companies where not everyone does it from a different perspective, you can more easily identify and invest in successful companies.
- Don’t be afraid to pass the deal at first-but keep in touch when you see the potential
Today’s market is so competitive, if you just heard that a hot start-up company is raising funds, it may be too late to make a deal. This is why one of the secrets of our successful transaction procurement is what we call the “track through”, which is essentially a system for keeping in touch with companies that are not involved in the transaction. quite In our investment stage, but may be the ideal choice for future investment. We often encounter companies that are at an earlier stage than our investment, but we have proven our differentiated advantages early on, allowing us to provide advice and guidance, and to keep in touch in a continuous and programmatic way.
Devise a way to identify winners with Staying in touch will not only help ensure that promising companies do not deviate from your sight, but it will also allow you to continue to develop your relationship with their leadership team.This way, when they do reach a stage worthy of your investment and are ready for another round of financing, you are more likely to win the deal because a) you will know it faster and b) they will know youWhen the founder has understood your abilities, your style as an investor and board member, and the value you bring, this is half the battle.
- Show the actual value you bring
An important reason why we won the thirty Madison deal is to prove the strength and breadth of our ecosystem and our ability to expand our business. In addition to capital, we also provide them with opportunities to contact individuals and ecosystems to accelerate their business. For example, my partner Randy Scott is valuable to the Thirty Madison team as a resource and mentor. He uses his extensive expertise as a medical technology entrepreneur and investor, as well as his work in Lens Crafters (early disruptors in the healthcare field) The experience of the founding team) and Procter & Gamble. We also introduced the company to select members of the advisory board with experience in leading blue-chip healthcare organizations, including the former CEO of Aon Hewitt who advises on further penetration of the employer market, and advises on best practices in the following areas The former president of Procter & Gamble. Consumer healthcare.
In order to differentiate yourself from the competition, in addition to simple capital, you can also bring additional resources or value to the transaction. What services can your company provide founders that others cannot provide? Can you provide connectivity, advice, and industry or management expertise? There is no price tag for transformative value. Prove to founders that your company will prepare for their long-term success, which is far greater than the impact of capital alone.
- Truly believe in their team and core business
A start-up company can have the most innovative, beneficial, and most popular concept on the planet, but without a reliable management team and the ability to run a profitable business, that doesn’t mean much. This is just a bet.
When reviewing potential customers, remove the potential future from the equation and look at the baseline of the business: Do they have a good and reliable management team? Even if all other companies fail, can they maintain the profitability of their core business?
For example, the thirty Madison co-founders Steven Gutentag and Demetri Karagas proved that they are not only capable of starting a competitive and innovative company, but also capable of running their core hair loss business profitable, In addition to entering new markets through three new brands and planned corporate expansion. They also recently appointed Eli Lilly veteran Michelle Carnahan as president of the company, supplementing their consumer expertise with deep pharmaceutical industry expertise and networking, significantly enhancing their leadership force. In short, we are confident in the complementarity of their teams.
Treat every investment in this spirit, and in the end, you are more likely to achieve the best results and cooperate with outstanding, high-potential companies.
In an extremely competitive market, building long-term relationships with promising startups can be difficult. The most successful investment companies focus on identifying winning companies as early as possible, keeping in touch until the time is right, and then using the additional value they can provide to differentiate themselves from the competition.
Photo: alphaspirit, Getty Images
Editor’s note: Our editorial guidelines for the above influencer articles clearly state that self-promotion is not allowed. As with all good rules, there are exceptions. This article is also true-the investment environment of health technology is indeed fiercely competitive, and this article will discuss how to manage the world.
